The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: A double-blind randomized-controlled study

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 5, 2005, Pages 381-385

  Vahedi, H ^a   Merat, S ^a   Rashidioon, A ^a   Ghoddoosi, A ^a   Malekzadeh, R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ANOREXIA; ANXIETY; ARTICLE; BLOATING; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; ESOPHAGITIS; FECES ANALYSIS; FEMALE; HEADACHE; HUMAN; INSOMNIA; IRRITABLE COLON; MALE; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREMOR;

ABDOMINAL PAIN; ADULT; CONSTIPATION; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 24344474273     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02566.x     Document Type: Article

References (18)

1. Camilleri M. Review article: Tegaserod. Aliment Pharmacol Ther 2001; 15: 277-89.
2. Muller-Lissner S, Holtmann G, Rueegg P, Weidinger G, Loffler H. Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2005; 21: 11-20.
3. Myren J, Lovland B, Larssen SE, Larsen S. A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol 1984; 19: 835-43.
4. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652-68.
5. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000; 108: 65-72.
6. O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999; 48: 980-90.
7. Gram L. Fluoxetine. N Engl J Med 1994; 331: 1354-61.
8. Kuiken SD, Tytgat GN, Boeckxstaens GE. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol 2003; 1: 219-28.
9. Shahbazkhani B, Forootan M, Merat S, et al. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 231-5.
10. Clouse RE, Lustman PJ, Geisman RA, Alpers DH. Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience. Aliment Pharmacol Ther 1994; 8: 409-16.
11. Gorard DA, Libby GW, Farthing MJ. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 159-66.
12. Talley NJ. SSRIs in IBS: sensing a dash of disappointment. Clin Gastroenterol Hepatol 2003; 1: 155-9.
13. Miwa J, Echizen H, Matsueda K, Umeda N. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion 2001; 63: 188-94.
14. Hirsch M, Birnbaum RJ. Pharmacology and use of antidepressants. In: Rose, BD, ed. UpToDate. Wellesley, MA, USA: UpToDate, 2005.
15. Creed F, Fernandes L, Guthrie E, et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003; 124: 303-17.
16. Tabas G, Beaves M, Wang J, Friday P, Mardini H, Arnold G. Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial. Am J Gastroenterol 2004; 99: 914-20.
17. Aranth J, Lindberg C. Bleeding, a side effect of fluoxetine. Am J Psychiatry 1992; 149: 412.
18. Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ. Fluoxetine and bleeding in obsessive-compulsive disorder. Am J Psychiatry 1991; 148: 949.